NL-OMON28081招募中不适用
Phase III study comparing R-CODOX-M/R-IVAC versus dose-adjusted EPOCH-R (DA-EPOCH-R) for patients with newly diagnosed high risk Burkitt lymphoma
Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON) P/a HOVON Data CenterErasmus MC Cancer Institute, Clinical Trial CenterP.O. Box 20403000 CA RotterdamTel: 010 4391568Fax: 010 4391028e-mail: hdc@erasmusmc.nl0 个研究点目标入组 260 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 260
研究概览
简要总结
ot yet for this trial.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •First diagnosis of high risk Burkitt lymphoma (sporadic and
- •HIV associated), histologically confirmed according to the
- •WHO classification 2008. Upon its availability the WHO 2016
- •classification should be used, to replace the WHO 2008
- •classification;
排除标准
- •- All histopathological diagnoses other than Burkitt
- •lymphoma according to the WHO classification 2008,
- •irrespective of the presence of a MYC rearrangement. Upon
- •its availability the WHO 2016 classification should be used, to
- •replace the WHO 2008 classification;
研究者
相似试验
进行中（未招募）
1 期
Phase III study comparing R-CODOX-M/R-IVAC versus dose-adjusted EPOCH-R (DA-EPOCH-R) for patients with newly diagnosed high risk Burkitt lymphomaEUCTR2013-004394-27-BEHOVON Foundation260
招募中
3 期
Phase III study comparing R-CODOX-M/R-IVAC versus dose-adjusted EPOCH-R (DA-EPOCH-R) for patients with newly diagnosed high risk Burkitt lymphomaNL-OMON53047HOVO90
进行中（未招募）
1 期
A clinical study comparing two different chemotherapy options for patients with newly diagnosed Burkitt lymphomaHigh-risk Burkitt lymphomaMedDRA version: 20.0Level: LLTClassification code 10006605Term: Burkitt's tumor or lymphomaSystem Organ Class: 100000004864EUCTR2013-004394-27-GBHOVON Foundation260
进行中（未招募）
1 期
Phase III study comparing R-CODOX-M/R-IVAC versus dose-adjusted EPOCH-R (DA-EPOCH-R) for patients with newly diagnosed high risk Burkitt lymphomaHigh risk Burkitt LymphomaMedDRA version: 20.0 Level: LLT Classification code 10006605 Term: Burkitt's tumor or lymphoma System Organ Class: 100000004864EUCTR2013-004394-27-NLHOVON Foundation260
已完成
2 期
Phase II study of R-CODOX-M/R-IVAC therapy for the patients with newly diagnosed primary mediastinal large B-cell lymphomaPrimary mediastinal large B-cell lymphomaJPRN-UMIN000003793ational Cancer Center Hospital35